Literature DB >> 2836876

A role played by sigma receptors in the conditioned suppression of motility in mice.

T Nabeshima1, H Kamei, T Kameyama.   

Abstract

Mice exhibited marked suppression of motility (conditioned suppression) when placed in the same environment in which they had previously received an electric footshock. The conditioned suppression was attenuated by cyclazocine and N-allylnormetazocine (SKF-10047), sigma agonists. The effect of these drugs was reduced by chronic pretreatment with cyclazocine. This behavioral change was related to the change in binding activity of [3H]-phencyclidine to sigma receptors (defined using non-radioactive SKF-10047). In the chronic vehicle-pretreated conditioned suppression group, the Kd and Bmax values of [3H]-phencyclidine binding at the high affinity site were increased when compared to those in the chronic vehicle-pretreated control group. The increased values were restored to the control levels by acute treatment with cyclazocine and SKF-10047. On the other hand, in the chronic cyclazocine-pretreated conditioned suppression group, acute cyclazocine and SKF-10047 treatment failed to change the increased values of Kd and Bmax at the high affinity site. The present behavioral and receptor-binding experiments suggest that the activation of nervous system mediated by sigma receptors may be responsible for the attenuation of conditioned suppression of motility.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2836876     DOI: 10.1007/BF00212847

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  35 in total

1.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog.

Authors:  W R Martin; C G Eades; J A Thompson; R E Huppler; P E Gilbert
Journal:  J Pharmacol Exp Ther       Date:  1976-06       Impact factor: 4.030

2.  Sigma opioid receptor: characterization and co-identity with the phencyclidine receptor.

Authors:  L G Mendelsohn; V Kalra; B G Johnson; G A Kerchner
Journal:  J Pharmacol Exp Ther       Date:  1985-06       Impact factor: 4.030

3.  [3H]U-69593 a highly selective ligand for the opioid kappa receptor.

Authors:  R A Lahti; M M Mickelson; J M McCall; P F Von Voigtlander
Journal:  Eur J Pharmacol       Date:  1985-02-26       Impact factor: 4.432

4.  Differences of alteration in opioid systems induced by conditioned suppression and electric footshock in mice.

Authors:  T Kameyama; T Nabeshima; K Yamada
Journal:  Pharmacol Biochem Behav       Date:  1985-02       Impact factor: 3.533

5.  The effects of opiate antagonists on food intake are stereospecific.

Authors:  D J Sanger; P S McCarthy; G Metcalf
Journal:  Neuropharmacology       Date:  1981-01       Impact factor: 5.250

6.  Interactions between narcotic agonists, partial agonists and antagonists evaluated by schedule-controlled behavior.

Authors:  R A Harris
Journal:  J Pharmacol Exp Ther       Date:  1980-06       Impact factor: 4.030

7.  Effect of naloxone on a quickly learned conditioned suppression in rats following cessation of chronic haloperidol treatment.

Authors:  T Kameyama; M Nagasaka
Journal:  Brain Res       Date:  1983-09-26       Impact factor: 3.252

8.  Contribution of different opioid systems to footshock-induced analgesia and motor suppression.

Authors:  T Nabeshima; K Yamada; T Kameyama
Journal:  Eur J Pharmacol       Date:  1983-09-02       Impact factor: 4.432

9.  Phencyclidine (angel dust)/sigma "opiate" receptor: visualization by tritium-sensitive film.

Authors:  R Quirion; R P Hammer; M Herkenham; C B Pert
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

10.  Characterization of specific binding sites for [3H](d)-N-allylnormetazocine in rat brain membranes.

Authors:  Y Itzhak; J M Hiller; E J Simon
Journal:  Mol Pharmacol       Date:  1985-01       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.